Partners Innovation Fund

Partners Innovation Fund

Partners Innovation Fund

Partners HealthCare is a notforprofit health care system that is committed to patient care, research, teaching, and service to the community locally
Follow us
Xconomy

Akouos Aims for an IPO to Advance Hearing Loss Gene Therapy to Clinic

$50,000,000 Venture capital (Series A)
FinSMEs

Rome Therapeutics Raises $50M in Series A Financing

$52,000,000 Venture capital (Series A)
FinSMEs

SwanBio Therapeutics Raises $52M in Series A

$60,000,000 Venture capital (Series A)
FinSMEs

Affinia Therapeutics Raises $60M in Series A Financing

$105,000,000 Venture capital (Series B)
FinSMEs

Akouos Raises $105M in Series B Financing

$105,000,000 Venture capital (Series B)
Pulse 2.0

Precision Genetic Medicine Company Akouos Secures $105 Million In Funding

the home of AI info

Comparing of Minerva Neurosciences Inc. (NERV) and Magenta Therapeutics Inc. (NASDAQ:MGTA)

MedCity News

Editas Medicine CEO steps down as company moves into product development stage

FinSMEs

Alexion To Acquire Syntimmune, for Up To $1.2 Billion

Health
$50,000,000 Venture capital (Series A)
FinSMEs

Precision Genetic Medicine Company Akouos Raises $50M in Series A

Science Funding Health
$100,000,000 IPO
PE HUB

Magenta Therapeutics starts trading on the NASDAQ

Stock markets Health
$52,000,000 Venture capital (Series C)
Venture Funding News , PE HUB

Magenta Therapeutics Secures $52M in Series C

FinSMEs

Magenta Therapeutics Secures $52M in Series C Financing

Funding Health
PE HUB

| Apple Tree-backed Syntimmune appoints president and CEO

Strategy Health
PE HUB

VC-backed Spero Therapeutics sets IPO pricing terms

Stock markets Funding
PE HUB

VC-backed Spero Therapeutics files for IPO

Stock markets Health Funding
$20,000,000 Venture capital (Series D)
prnewswire

Sebacia Announces $36 Million Equity and Debt Financing to Advance Breakthrough In-Office Procedure for Acne

Xconomy

Syntimmune Snares $50M to Test Autoimmune Drug in Two Rare Diseases

Health Science
$50,000,000 Venture capital (Series B)
PE HUB , Xconomy

Magenta Therapeutics takes in $50 mln Series B

Funding Messaging
$51,700,000 Venture capital (Series C)
Spero Therapeutics

Spero Therapeutics Secures $51.7 Million in Oversubscribed Series C Financing